Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial

American Journal of Obstetrics and Gynecology
S Cowchock, E A Reece

Abstract

We identified 19 women who had persistently positive test results for antiphospholipid antibodies who were considered to be at low risk because they had none of the associated signs or symptoms of the antiphospholipid antibody syndrome. They had had no (10/19, 53%) or just one prior spontaneous abortion and did not have a history of thrombosis or thrombocytopenia. Many (8/19, 42%) had had a prior uncomplicated pregnancy ending in a live birth. These women were randomly assigned to receive low-dose aspirin (81 mg daily) or usual care. There were few obstetric complications recorded in either treatment group. One woman in the aspirin group had a fetal death, and one in the usual care group had a low-birth-weight infant. The frequency of complications was so low that > 600 such women would need to be entered into a randomized trial to evaluate whether low-dose aspirin would be beneficial treatment during a pregnancy. We concluded that treatment of pregnant women with antiphospholipid antibodies who are otherwise at low risk cannot be justified on the basis of the available evidence.

Citations

May 16, 2001·Current Rheumatology Reports·L R Sammaritano
Apr 14, 2005·Best Practice & Research. Clinical Endocrinology & Metabolism·Lorin Lakasing, Catherine Williamson
Jun 15, 2013·Human Reproduction Update·Paulien G de JongSaskia Middeldorp
Aug 3, 2010·Archives of Gynecology and Obstetrics·Ana Carolina S CalderonRicardo C Cavalli
Dec 11, 2007·Best Practice & Research. Clinical Rheumatology·Guillermo Ruiz-Irastorza, Munther A Khamashta
Feb 9, 2012·British Journal of Haematology·David KeelingUNKNOWN British Committee for Standards in Haematology
Sep 6, 2001·Rheumatic Diseases Clinics of North America·H A ShehataM A Khamashta
Aug 24, 2001·American Journal of Obstetrics and Gynecology·G Ruiz-IrastorzaM A Khamashta
Sep 12, 2006·Obstetrics and Gynecology Clinics of North America·Francesco Dentali, Mark Crowther
Jan 24, 2007·Journal of Reproductive Immunology·R H W M Derksen, Ph G de Groot
May 15, 2007·Rheumatic Diseases Clinics of North America·Guillermo Ruiz-Irastorza, Munther A Khamashta
Sep 6, 2001·Rheumatic Diseases Clinics of North America·J T Merrill
Oct 16, 2004·Lupus·H Carp
Apr 20, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M Akif OztürkHakan Göker
Jul 14, 2018·The Cochrane Database of Systematic Reviews·Malgorzata M BalaAnetta Undas
Apr 13, 2004·Arthritis and Rheumatism·Ronald H W M DerksenD Ware Branch
Apr 23, 2005·The Cochrane Database of Systematic Reviews·M EmpsonJ Scott
Nov 22, 2018·BJOG : an International Journal of Obstetrics and Gynaecology·P P SmithT J Clark
Dec 18, 2018·The Cochrane Database of Systematic Reviews·Aleena M WojcieszekVicki Flenady
Nov 29, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Chang LuHai-Li Jiang
Jan 9, 2019·Expert Review of Clinical Immunology·Amelia RuffattiTeresa Del Ross
Dec 18, 2007·Obstetrical & Gynecological Survey·Andra H JamesThomas Price
Aug 14, 2010·Journal of Thrombosis and Haemostasis : JTH·D M CohnR G Farquharson
Oct 27, 2018·Minerva ginecologica·Micaela Della TorreLaura M Digiovanni
Apr 20, 2007·The Cochrane Database of Systematic Reviews·L DuleyJ F King
May 28, 2010·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Francesca Monari, Fabio Facchinetti
Oct 11, 2014·Expert Review of Clinical Immunology·Cecilia Beatrice ChighizolaPier Luigi Meroni
May 17, 2019·Annals of the Rheumatic Diseases·Maria G TektonidouMichael M Ward
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Lelia DuleyLisa M Askie
Nov 28, 2001·Hematology·B G MacikB A Konkle
Apr 9, 2020·Chinese Medical Journal·Yu ZuoJason S Knight
Mar 17, 2009·Expert Opinion on Pharmacotherapy·Gerard Espinosa, Ricard Cervera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.